CLINICAL_TRIALS
trial_result
· 2015-09-02
Clinical Trial Update: Study of BN83495 in Post-menopausal Women With Endometrial Cancer Post-chemotherapy [Phase 2]
Summary
Phase 2 trial of BN83495 in postmenopausal women with endometrial cancer after chemotherapy was terminated; results posted in 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ipsen | Conditions: Endometrial Cancer | Phase 2 | Status: TERMINATED | Results posted: 2015-09-02